Who Paid My Doc
Daniel Buchbinder
Oral & Maxillofacial Surgery New York, NY Doctor of Dentistry
NPI 1407835390 CMS profile 109668
10 Union Sq E, Suite 5B, New York, NY 10003
General payments
$69,176
Research payments
$0
Ownership & investment interest
$3,025,506
Through program year 2025, Daniel Buchbinder of New York, NY is reported in the CMS Open Payments database as having received $69,176 across 87 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $3,025,506 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $106 | 2 | |
| 2023 | General | $12,686 | 22 | |
| 2022 | General | $15,623 | 16 | |
| 2021 | General | $13,172 | 13 | |
| 2020 | General | $6,893 | 13 | |
| 2019 | General | $20,698 | 21 | |
| 2025 | Ownership | $352,564 | 1 | |
| 2024 | Ownership | $352,564 | 1 | |
| 2023 | Ownership | $716,892 | 1 | |
| 2022 | Ownership | $609,162 | 1 | |
| 2021 | Ownership | $497,162 | 1 | |
| 2020 | Ownership | $497,162 | 1 |
Beside peers
- Daniel Buchbinder
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Daniel Buchbinder were reported at $106. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Daniel Buchbinder | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $20,698 | $178 | $56–$584 | $163 |
| 2020 | $6,893 | $106 | $38–$316 | $114 |
| 2021 | $13,172 | $165 | $57–$511 | $132 |
| 2022 | $15,623 | $173 | $63–$494 | $149 |
| 2023 | $12,686 | $184 | $62–$521 | $160 |
| 2024 | $0 | $197 | $65–$603 | $164 |
| 2025 | $106 | $184 | $61–$541 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 34 billing codesPaid by Medicare
$46,441
Medicare patients
116
Services billed
255
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 63% | |
| Arthritis | 49% | |
| Ischemic heart disease | 32% | |
| Osteoporosis | 25% | |
| Depression | 24% | |
| Diabetes | 19% | |
| Cancer | 18% | |
| Chronic kidney disease | 14% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
87 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in New York
Jay Neugarten
Oral & Maxillofacial Surgery · Lake Success, NY
Yan Trokel
Oral & Maxillofacial Surgery · New York, NY
Michael Markiewicz
Oral & Maxillofacial Surgery · Buffalo, NY
Al Haitham Al Shetawi
Oral & Maxillofacial Surgery · Poughkeepsie, NY
Thomas Frawley
Oral & Maxillofacial Surgery · Hamburg, NY
Andrea Torroni
Oral & Maxillofacial Surgery · New York, NY
Related records
Oral & Maxillofacial Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.